Consecutive Accreditation-Financial Results-Joint Commission-Clinical Quality-Medical Clinics

CVS Caremark's MinuteClinic Is First Retail Clinic Provider to Earn Gold Seal of Approval™ from The Joint Commission for Three Consecutive Accreditation Periods

WOONSOCKET, R.I., Aug. 6, 2012 /PRNewswire/ -- Building on its established record for clinical quality, MinuteClinic, the walk-in medical clinics inside CVS/pharmacy, has become the first retail clinic provider to achieve three consecutive accreditation awards from The Joint... read more..

source:http://www.pharmainfo.net

China Nepstar Chain Drugstore to Report Second Quarter 2012 Financial Results on August 23, 2012

SHENZHEN, China, Aug. 6, 2012 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its second... read more..

source:http://www.pharmainfo.net

IBA Molecular y Piramal Imaging firman un acuerdo para el nuevo agente de imagen amiloide F-18

- IBA Molecular fabricará y distribuirá 18F-Florbetaben en Europa y Estados Unidos
DULLES, Virginia y BOMBAY, la India, 6 de agosto de 2012 /PRNewswire/ -- IBA Molecular y Piramal Imaging SA (Piramal) han anunciado un acuerdo a través del cual IBA Molecular fabricará y... read more..

source:http://www.pharmainfo.net

Biopharmaceutical Company-Herborium Group Reports-Phase 2 Clinical Trial-Mycobacteria

Med Centro Becomes First SuccessEHS Client to Go Live in Puerto Rico

BIRMINGHAM, Ala., June 27, 2012 /PRNewswire/ -- On June 5, 2012, Med Centro became the first SuccessEHS client in Puerto Rico to go live with the SuccessEHS solution, expanding the vendor's existing coverage in 48 states and the Virgin Islands.The go-live on June 5 took place... read more..

source:http://www.pharmainfo.net

Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

MONMOUTH JUNCTION, N.J., June 27, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's U.S. phase 2 clinical study of ARIKACE® (liposomal amikacin for inhalation) in... read more..

source:http://www.pharmainfo.net

Herborium Group Reports Record 6 Month Revenues

FORT LEE, N.J., June 27, 2012 /PRNewswire/ -- Herborium Group, Inc., ( HBRM) www.herborium.com, a Botanical Therapeutics® Company announces today that its revenues   from AcnEase®, all botanical, proprietary acne treatment, grew over 25 percent in  the first ... read more..

source:http://www.pharmainfo.net

Post-Traumatic Stress Disorder-Triwest Healthcare Alliance-Reimbursement Revenue

Kick Off Summer Vacation With Five Simple Tips to Safely Store Medicines While Traveling

Kick Off Summer Vacation With Five Simple Tips to Safely Store Medicines While Traveling
As Americans Pack Their Bags, CDC and CHPA Educational Foundation Remind Families to Pack Medicines Safely, Too WASHINGTON, June 27, 2012 /PRNewswire-USNewswire/ -- With summer here and... read more..

source:http://www.pharmainfo.net

TriWest Healthcare Alliance Stands With Military Partners In Recognizing Post-Traumatic Stress Disorder Awareness Day

PHOENIX, June 27, 2012 /PRNewswire/ -- While today marks Post-Traumatic Stress Disorder (PTSD) Awareness Day,  TriWest Healthcare Alliance remains firm in its commitment to stand alongside its U.S. military and TRICARE partners in the mission to prevent PTSD and the effects it has on... read more..

source:http://www.pharmainfo.net

California Pathology Practice Increases Reimbursement by 40%

ATLANTA, June 27, 2012 /PRNewswire/ -- Today's pathology practices face increasing billing complexities. Coding regulations are complicated, and penalties can be stiff if errors are made. Some physician groups miss valuable reimbursement revenue for certain services because they... read more..

source:http://www.pharmainfo.net

Teva Pharmaceutical Industries Ltd-Medical Device Company-Cancer Pharmaceuticals

InspireMD Announces Enrollment Completion In Master Trial

TEL AVIV, Israel, May 24, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial... read more..

source:http://www.pharmainfo.net

Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D

ORANGE COUNTY, Calif., May 24, 2012 /PRNewswire/ -- Dr. James Smith, President of NanoSmart Pharmaceuticals, Inc., a California corporation developing a novel drug-delivery platform for cancer pharmaceuticals, announced today that the company has added Dr. Paul Glidden as Vice... read more..

source:http://www.pharmainfo.net

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update
Bloomberg - 15 minutes ago
Teva Pharmaceutical Industries Ltd. (TEVA) rose the most in almost two months before new Chief Executive Officer Jeremy Levin gives an update on financial guidance. read more..

source:http://www.pharmainfo.net

Glenmark Pharma-Couple Of Days

Sukhani not upbeat on Glenmark Pharma

Sukhani not upbeat on Glenmark Pharma
Moneycontrol.com - 31 minutes ago
Sukhani told CNBC-TV18, “KPIT Cummins has moved well. It had a very big day. It's consolidated for a couple of days and then continued its run. read more..

source:http://www.pharmainfo.net

Novartis Pharmaceuticals Corporation-Professional Women-Phil Keoghan-Awareness-Cyclists

TV host Phil Keoghan and professional women cyclists join Novartis to raise awareness of multiple sclerosis

EAST HANOVER, N.J., May 8, 2012 /PRNewswire/ -- Phil Keoghan, host of "The Amazing Race," and the women cyclists of the professional "NOW and Novartis for MS" team are joining with Novartis Pharmaceuticals Corporation for a second year in a row to raise awareness of MS. The campaign,... read more..

source:http://www.pharmainfo.net

Watson Pharmaceuticals-Diabetic Macular Edema-Ampio Pharmaceuticals-Iridex Corporation

IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma

MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire/ -- IRIDEX Corporation today announced the launch of a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse™ technology.  The new glaucoma therapy, a tissue-sparing, repeatable therapy called... read more..

source:http://www.pharmainfo.net

Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing... read more..

source:http://www.pharmainfo.net

Equinix, Watson Pharmaceuticals Among Stocks Hitting 52-Week Highs Thursday

Equinix, Watson Pharmaceuticals Among Stocks Hitting 52-Week Highs Thursday
Fox Business - 18 hours ago
While trading on above-average volume, Equinix (EQIX) climbed today, reaching and then surpassing its previous 52-week high of $161.56. read more..

source:http://www.pharmainfo.net

Ranbaxy Laboratories-Malaria Treatment-Malaria Drug

From copycat, Ranbaxy emerges drugmaker

From copycat, Ranbaxy emerges drugmaker
mydigitalfc.com - 18 hours ago
By Abhinav Kaul Apr 25 2012 , New Delhi treatment of uncomplicated Plasmodium falciparum malaria in adults. This puts India in the elite club of new drug developer countries. read more..

source:http://www.pharmainfo.net

Synriam is a CSR initiative, it will not bring us significant profits

Synriam is a CSR initiative, it will not bring us significant profits
Livemint - 17 hours ago
Ranbaxy Laboratories launched India's first indigenously developed drug for malaria treatment, Synriam, on the occasion of World Malaria Day on Wednesday. read more..

source:http://www.pharmainfo.net

Ranbaxy launches malaria drug Synriam

Ranbaxy launches malaria drug Synriam
Livemint - Apr 25, 2012
New Delhi: Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduce it in other Asian countries, Africa and South America. read more..

source:http://www.pharmainfo.net

Global Medical Technology Company-Natus Medical Incorporated-Health Supplement Products

CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million

SAN DIEGO and SAN CARLOS, Calif., April 23, 2012 /PRNewswire/ -- CareFusion (NYSE: CFN), a global medical technology company, and Natus Medical Incorporated (NASDAQ: BABY), a leading provider of health care screening, diagnostic and treatment products, today announced that they have... read more..

source:http://www.pharmainfo.net

Biostar Pharmaceuticals, Inc. To Supply All Hospitals In Three Chinese Provinces With Huangyangning Tablets

XIANYANG, China, April 23, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today... read more..

source:http://www.pharmainfo.net

Once-daily oral anticoagulant receives positive Common Drug Review recommendation for stroke prevention in atrial fibrillation

Bayer Inc. welcomes support for public reimbursement of new treatment TORONTO, April 23, 2012 /PRNewswire/ - Hundreds of thousands of Canadians
living with atrial fibrillation (AF) are now one step closer to getting
public reimbursement for a new stroke prevention therapy -... read more..

source:http://www.pharmainfo.net

University Of Tennessee Lady Vols-Alzheimer's Association-National Alzheimer-Tyler Summitt

Alzheimer's Association to Honor Legendary University of Tennessee Lady Vols Head Coach Emeritus Pat Summitt and Son Tyler at National Alzheimer's Dinner

WASHINGTON, April 23, 2012 /PRNewswire-USNewswire/ -- The Alzheimer's Association will present University of Tennessee Women's Basketball Head Coach Emeritus Pat Summitt and her son, Tyler Summitt, with its Sargent and Eunice Shriver Profiles in Dignity Award at the Alzheimer's... read more..

source:http://www.pharmainfo.net

Picosecond Laser Platform Technology-Pulmonary Function Testing-Electronic Medical Record

Crowell Systems - Medformix® and nSpire Health™ - KoKo Spirometer Announce the First Bi-Directional Interface Connecting Patient Electronic Records to Pulmonary Lung Testing Equipment

CHARLOTTE, N.C., April 19, 2012 /PRNewswire/ -- Crowell Systems, a leading electronic medical record manufacturer, and nSpire Health, the nation's leading pulmonary function testing systems worldwide, have announced the first bi-directional interface connecting patient electronic records... read more..

source:http://www.pharmainfo.net

Cynosure Announces Presentations and Published Abstracts on Cellulaze™ and New Picosecond Laser Platform Technology at 32nd ASLMS Conference

WESTFORD, Mass., April 19, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced an invited presentation and three published abstracts demonstrating favorable results for the Company's picosecond Alexandrite laser technology, which is designed for multiple applications,... read more..

source:http://www.pharmainfo.net

Utilization Management-Fractional Resurfacing-Global Market Leader-Aesthetic Treatments

Specialty pharmacy utilization management proves effective

SAN FRANCISCO, April 19, 2012 /PRNewswire/ -- Utilization management (UM) programs such as prior authorizations (PAs) can be used to improve safety and efficacy as well as cost-effectiveness for specialty drugs, according to two new studies being presented tomorrow by Prime... read more..

source:http://www.pharmainfo.net

Solta Medical's Clear + Brilliant™ Resurfacing Device Demonstrates Significant Reduction of Pore Count and Pore Size

HAYWARD, Calif., April 19, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, today announced the results of a first-of-its-kind, IRB-approved clinical study that evaluated the use of its... read more..

source:http://www.pharmainfo.net

InterMune To Release First Quarter Financial Results On April 26

BRISBANE, Calif., April 19, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2012 financial results at the close of the U.S. markets on Thursday, April 26, 2012.  A live conference call and webcast will be hosted by... read more..

source:http://www.pharmainfo.net

Adventrx Pharmaceuticals-Senior Advisory Board-Sickle Cell Disease-The Martin Center

ADVENTRX Pharmaceuticals to Sponsor "Present at the Martin Center's 2012 Sickle Cell Disease Conference

SAN DIEGO, April 16, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company is a sponsor of and will be presenting at the Martin Center's 2012 Indiana Statewide Sickle Cell Disease Conference at the Indiana Landmarks Center in... read more..

source:http://www.pharmainfo.net

Like this story, share it with millions of investors on M3

Like this story, share it with millions of investors on M3
Moneycontrol.com - 8 minutes ago
However, Tulsian has a negative view of IVRCL and is doubtful that the correct company's valuations would be reflected in the books of the Essel Group. read more..

source:http://www.pharmainfo.net

Jefferies Appoints Global Senior Advisory Board

Jefferies Appoints Global Senior Advisory Board
MarketWatch (press release) - 6 minutes ago
NEW YORK, Apr 16, 2012 (BUSINESS WIRE) -- Jefferies today announced that it has appointed six distinguished executives to its Global Senior Advisory Board: Mr. read more..

source:http://www.pharmainfo.net

Dermatologic Society-Licensing Agreement-Biologic Therapies-Clinical Trial-Prnewswire

Women's Dermatologic Society (WDS) Announces 2012-2013 Leadership and Honorees

ALEXANDRIA, Va., March 28, 2012 /PRNewswire/ -- The Women's Dermatologic Society (WDS), the nation's third largest dermatologic organization, announces its 2012-2013 Officers, Board of Directors and annual honorees, as presented at the 37th Annual Meeting Luncheon held recently in... read more..

source:http://www.pharmainfo.net

First Patient Treated in Trillium's Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial

TORONTO, March 28, 2012 /PRNewswire/ - Trillium Therapeutics Inc., a
privately-held biopharmaceutical company developing proprietary and
innovative biologic therapies, today announced that it has dosed the
first patient in a phase I clinical trial evaluating TTI-1612, an... read more..

source:http://www.pharmainfo.net

Sequent Medical and Inceptus Medical Announce a Licensing Agreement on MicroBraid Technology

ALISO VIEJO, Calif., March 28, 2012 /PRNewswire/ -- Sequent Medical, Inc. and Inceptus Medical, LLC announced today an agreement that provides Inceptus Medical with a license to Sequent Medical's MicroBraid™ technology for use in select medical device applications. Sequent... read more..

source:http://www.pharmainfo.net

Aesthetic Plastic Surgery-Medical Device Company-Deep Brain Stimulation-Stereotactic Surgery

Third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium Brings Industry Leading Courses and Programming to New York City

New York, March 21, 2012 /PRNewswire/ -- The third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium will be held on July 20-22, 2012 at the Conrad New York, a new luxury complex overlooking the Hudson River in lower Manhattan. This interactive,... read more..

source:http://www.pharmainfo.net

UCLA Professor of Neurosurgery and NeuroSigma Co-Founder Honored for Groundbreaking Work including Deep Brain Stimulation for Treatment of PTSD

LOS ANGELES, March 21, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, is pleased to recognize the accomplishments of Antonio A.F. De Salles, M.D., Ph.D., Professor of Neurosurgery and Head of the Stereotactic Surgery Division of the Department... read more..

source:http://www.pharmainfo.net

Methylene Diphenyl Diisocyanate-Clinical Trial Management-Clinical Trials Industry

DATATRAK Exhibits at CBI's 5th Annual Forum on CTMS

CLEVELAND, March 19, 2012 /PRNewswire / -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its attendance at CBI's 5th Annual Forum on Clinical Trial Management Systems... read more..

source:http://www.pharmainfo.net

Methylene Diphenyl Diisocyanate (MDI) Market is Expected to Reach USD 16.0 Billion by 2016: Transparency Market Research

ALBANY, New York, March 19, 2012 /PRNewswire/ --According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Methylene Diphenyl Diisocyanate (MDI) Market: Global Market Analysis, Size, Share & Forecast (2009 - 2016)", Global... read more..

source:http://www.pharmainfo.net

Bone Marrow Transplant Arrests Symptoms in Model of Rett Syndrome

Results Emphasize Immune Component of Autism Spectrum DisorderTRUMBULL, Conn., March 19, 2012 /PRNewswire-USNewswire/ -- A paper published online in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome.... read more..

source:http://www.pharmainfo.net

Life Technologies Corporation-Energieforschung Geeignet-Bioscience Industry-Global Provider

Life Technologies Launches GeneArt® Precision TALs

CARLSBAD, Calif., March 19, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of GeneArt® Precision TALs, generally referred to as TAL effector proteins (TALE), which will allow researchers the ability to edit genomes and control gene.. read more..

source:http://www.pharmainfo.net

Life Technologies führt Präzisions-TAL-Effektoren GeneArt® ein

CARLSBAD, Kalifornien, March 19, 2012 /PRNewswire/ --- Lifes TAL-Effektorproteine ermöglichen eine präzise Bearbeitung von Genomen und sind zur Anwendung im Gesundheitswesen, der Landwirtschaft und der Energieforschung geeignetLife Technologies Corporation (NASDAQ:LIFE)... read more..

source:http://www.pharmainfo.net

BioStorage Technologies to Host Live Webinar on Optimizing the Value of Sample Assets

INDIANAPOLIS, March 19, 2012 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions, biomaterial storage and cold chain logistics for the bioscience industry, announced today that it will host a live, complimentary webinar titled,... read more..

source:http://www.pharmainfo.net

Biopharmaceutical Company-Varian Medical Systems-Chief Medical Officer-Predator Nutrition

ImmusanT Names Patrick Griffin as Chief Medical Officer, Expands Management Team

CAMBRIDGE, Mass., March 19, 2012  /PRNewswire/ -- ImmusanT announced today that Patrick H. Griffin, MD, has joined the biopharmaceutical company as Chief Medical Officer and Senior Vice President of Development, and Michelle Hipwood joins as Director of Finance and... read more..

source:http://www.pharmainfo.net

Varian Medical Systems Schedules Second Quarter FY2012 News Release and Conference Call

PALO ALTO, Calif., March 19, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for the second quarter of fiscal year 2012 following the close of regular trading on Wednesday, April 25, 2012.  The news release will be followed by a... read more..

source:http://www.pharmainfo.net

Predator Nutrition Founder Slams Latest Red Meat Research

BRADFORD, England, March 19, 2012 /PRNewswire/ --The founder of Predator Nutrition, Europe's leading sports supplements retailer and distributor, has questioned the validity of a recent study by Harvard School of Public Health that claims red meat consumption may increase the risk of... read more..

source:http://www.pharmainfo.net

Mental Health Medications-Psychotropic Medications-Men And Women

The Mental Health Gender Gap: Women Far Exceed Men in their Use of Psychotropic Medications as Utilization Increases Among Both Sexes

WASHINGTON, March 19, 2012 /PRNewswire/ -- Women far outpace their male counterparts when it comes to the consumption of mental health medications, with 25 percent using at least one psychotropic read more..

source:http://www.pharmainfo.net

More is Sometimes Less: Women are Prescribed a Greater Number of Medications Than Men but Take Less of the Drugs They Need

WASHINGTON, March 19, 2012 /PRNewswire/ -- There is a wide gender divide when it comes to how men and women are prescribed and adhere to their medications.  According to a new study, while women use more pr read more..

source:http://www.pharmainfo.net

Transformational Strategies-Kforce Clinical Research-Healthcare Supply Chain-Definitive Agreement

Transformational Strategies and Proven Results: The GHX Healthcare Supply Chain Summit 2012 Session Line-up

LOUISVILLE, Colo., March 19, 2012 /PRNewswire/ -- In its 12th year as the industry's largest event for healthcare supply chain leaders, GHX announced its breakout session line-up for the 2012 GHX Healthcare Supply Chain Summit taking place May 7-9, 2012 in Orlando, Florida. At this... read more..

source:http://www.pharmainfo.net

inVentiv Health To Acquire Kforce Clinical Research

BURLINGTON, Mass., March 19, 2012 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc.... read more..

source:http://www.pharmainfo.net

Merz Pharmaceuticals Introduces New Mederma® Advanced Scar Gel

GREENSBORO, N.C., March 19, 2012 /PRNewswire/ -- Mederma, the #1 doctor(1)-and pharmacist(2)-recommended brand for scars for over a decade, announced today the introduction of Mederma® Advanced Scar Gel, which reduces the overall appearance of scars caused by injury, acne,... read more..

source:http://www.pharmainfo.net